UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000019710 |
|---|---|
| Receipt number | R000022763 |
| Scientific Title | A retrospective study of treatments and prognosis of neuroendocrine tumor of endometrium |
| Date of disclosure of the study information | 2015/11/09 |
| Last modified on | 2019/11/12 14:31:06 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A retrospective study of treatments and prognosis of neuroendocrine tumor of endometrium
Acronym
A retrospective study of neuroendocrine tumor of endometrium
Scientific Title
A retrospective study of treatments and prognosis of neuroendocrine tumor of endometrium
Scientific Title:Acronym
A retrospective study of neuroendocrine tumor of endometrium
Region
| Japan |
Condition
Condition
Neuroendocrine tumor of endometrium
Classification by specialty
| Obstetrics and Gynecology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To clarify treatment and prognosis of neuroendocrine tumor of endometrium, and to obtain findings to establish future individualized treatment.
Basic objectives2
Others
Basic objectives -Others
Retrospective observational study
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
background factors, stage, tratments, pathological findings, prognosis
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
Patients diagnosed with neuroendocrine tumor of endometrium between 1995 and 2014.
Key exclusion criteria
1) Patients with a history of chemotherapy and/or radiotherapy for other malignancy.
2) Patients with a severe complication.
3) Patients who have other malignancies.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Harunobu |
| Middle name | |
| Last name | Matsumoto |
Organization
Faculty of Medicine, Oita University
Division name
Department of Obstetrics and Gynecology
Zip code
8795593
Address
1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 8795593, Japan
TEL
097-586-5922
matumoti@oita-u.ac.jp
Public contact
Name of contact person
| 1st name | Harunobu |
| Middle name | |
| Last name | Matsumoto |
Organization
Faculty of Medicine, Oita University
Division name
Department of Obstetrics and Gynecology
Zip code
8795593
Address
1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 8795593, Japan
TEL
097-586-5922
Homepage URL
matumoti@oita-u.ac.jp
Sponsor or person
Institute
Kansai Clinical Oncology Group
Institute
Department
Personal name
Funding Source
Organization
Kansai Clinical Oncology Group
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University
Address
1-1, Idaigaoka, Hasama-machi, Yufu-shi, Oita 8795593, Japan
Tel
097-586-5120
syomu@oita-u..ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 11 | Month | 09 | Day |
Related information
URL releasing protocol
http://www.med.oita-u.ac.jp/sanka/patient/index5.html
Publication of results
Published
Result
URL related to results and publications
https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Number of participants that the trial has enrolled
42
Results
Please refer to the link below.
https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Results date posted
| 2019 | Year | 05 | Month | 13 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
| 2019 | Year | 07 | Month | 01 | Day |
Baseline Characteristics
Please refer to the link below.
https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Participant flow
Please refer to the link below.
https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Adverse events
Not applicable
Outcome measures
Please refer to the link below.
https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 07 | Month | 24 | Day |
Date of IRB
| 2015 | Year | 07 | Month | 24 | Day |
Anticipated trial start date
| 2015 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2016 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This is a multi-center retrospective study.
Management information
Registered date
| 2015 | Year | 11 | Month | 09 | Day |
Last modified on
| 2019 | Year | 11 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022763
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
